Wei, A. Z., Bakir, B., Lenis, A. T., Anderson, C. B., Runcie, K., DeCastro, G. J., Pan, S. S., Shen, M. M., McKiernan, J. M., Stein, M. N. (2025). A phase 2, randomized, open-label study of gemcitabine/cisplatin plus cemiplimab (REGN2810, anti-PD-1) with or without fianlimab (REGN3767, anti-LAG-3) for organ preservation in patients with localized muscle-invasive bladder cancer (NeoSTOP-IT).. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.tps882